Mahamaya Lifesciences IPO GMP, Subscription & Allotment Status Today
Mahamaya Lifesciences is a SME IPO with a price band of Rs 108.00 to Rs 114.00 that listed on 18 Nov 2025 at a listing gain of +1.75%. Track its full GMP history, subscription data and listing details here.
- Price Band
- ₹108.00 - ₹114.00
- Lot Size
- TBA
- Bidding Closes
- TBA
- Listing Date
- 18 Nov 2025
Complete IPO information
| Current GMP | ₹2 |
|---|---|
| Estimated Listing Gain | +1.75% |
| Price Band | ₹108.00 - ₹114.00 |
| Issue Price | Approx ₹114.00 Crores |
| Listing Price | ₹116.00 |
| Lot Size | TBA |
| Issue Type | SME |
| Registrar | TBA |
| Exchange | NSE, BSE |
| Retail Quota | TBA |
| Overall Subscription | TBA |
| Listing Date | 18 Nov 2025 |
| Minimum Investment | TBA |
IPO Snapshot & Investor Takeaways
The latest recorded Grey Market Premium for Mahamaya Lifesciences stands at ₹2, implying an estimated listing gain of around 1.75% over the issue price if it holds until listing. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.
SME IPOs list on the dedicated SME platform of BSE/NSE. They usually involve smaller issue sizes and a higher per-lot investment than Mainboard issues, with comparatively lower institutional participation.
IPO roadmap at a glance
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 Lot | - | - |
| Retail Maximum | - | - | - |
| S-HNI Minimum | - | - | - |
| S-HNI Maximum | - | - | - |
| B-HNI Minimum | - | - | - |
Objects of the Issue & Official Documents
Important takeaways before applying
Listed at 116.0 for 1.75% gains
Mahamaya Lifesciences IPO FAQs
Comments
Share a useful question or insight about Mahamaya Lifesciences.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Loading comments...